Evidence map›Paper›PMID 25739051›Full record

ArticleThe Journal of investigative dermatology2015

Epidermal Expression and Regulation of Interleukin-33 during Homeostasis and Inflammation: Strong Species Differences.

Olav Sundnes, Wojciech Pietka, Tamara Loos, Jon Sponheim, Andrew L Rankin, Stefan Pflanz, Vibeke Bertelsen, Jan C Sitek, Johanna Hol, Guttorm Haraldsen and 1 more

Open access · bronzeAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Influence of Genetic Polymorphisms ofInternational journal of dentistry · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Observational
  18. Article
  19. IL-33 in Rheumatic Diseases.Frontiers in medicine · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Olav SundnesK.G.Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Wojciech PietkaK.G.Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Tamara LoosDepartment of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Jon SponheimK.G.Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Andrew L RankinDepartment of Immunology, Merck Research Laboratories (formerly Schering-Plough Biopharma/DNAX), Palo Alto, California, USA.
Stefan PflanzDepartment of Immunology, Merck Research Laboratories (formerly Schering-Plough Biopharma/DNAX), Palo Alto, California, USA.
Vibeke BertelsenDepartment of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Jan C SitekDepartment of Dermatology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Johanna HolK.G.Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Guttorm HaraldsenK.G.Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway. Electronic address: gharalds@rr-research.no.
Denis KhnykinK.G.Jebsen Inflammation Research Centre, University of Oslo and Oslo University Hospital, Oslo, Norway; Department of Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-33 is a novel IL-1 family member with a putative role in inflammatory skin disorders and a complex biology. Therefore, recent conflicting data regarding its function in experimental models justify a close assessment of its tissue expression and regulation. Indeed, we report here that there are strong species differences in the expression and regulation of epidermal IL-33. In murine epidermis, IL-33 behaved similar to an alarmin, being constitutively expressed in keratinocyte nuclei and rapidly lost during acute inflammation. By contrast, human and porcine IL-33 were weakly expressed or absent in keratinocytes of noninflamed skin but induced during acute inflammation. To this end, we observed that expression of IL-33 in human keratinocytes but not murine keratinocytes was strongly induced by IFN-γ, and this upregulation completely depended on the presence of EGFR ligands. Accordingly, IFN-γ increased the expression of IL-33 in the basal layers of the epidermis in human ex vivo skin cultures only, despite good evidence of IFN-γ activity in cultures from both species. Together these findings demonstrate that a full understanding of IL-33 function in clinical settings must take species-specific differences into account.

Indexed as

Gene Expression RegulationAdultAnimalsBiopsy, NeedleBlotting, WesternDermatitisDisease Models, AnimalEpidermisFemaleHomeostasisHumansImmunohistochemistryInflammationInterleukin-33InterleukinsKeratinocytesIL33 protein, humanIl33 protein, mouseInterleukin-33Interleukins

Identifiers

PMID25739051
OpenAlexW2090714019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.